Allarity Therapeutics, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Allarity Therapeutics, Inc. (ALLR) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$6.68 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2022-11-14
- Allarity Therapeutics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-09-30 was -$6.68M.
- Allarity Therapeutics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-06-30 was -$6.48M.
- Allarity Therapeutics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-03-31 was -$4.65M.
- Allarity Therapeutics, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2021-09-30 was -$1.35M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | -$6.68M 10-Q · filed 2022-11-14 | -$13.16M derived: sum of 2 quarters · filed 2022-11-14 | -$17.95M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$6.48M 10-Q · filed 2022-10-07 | -$11.27M 10-Q · filed 2022-10-07 | |||
| 2022-03-31 | -$4.65M 10-Q · filed 2022-05-27 | ||||
| 2021-09-30 | -$1.35M 10-Q · filed 2022-11-14 | $1.67M 10-Q · filed 2021-11-23 | -$6.75M derived: sum of 2 quarters · filed 2022-11-14 | -$9.83M 10-Q · filed 2022-11-14 | -$5.99M 10-Q · filed 2021-11-23 |
| 2021-06-30 | -$5.40M 10-Q · filed 2022-10-07 | -$8.48M 10-Q · filed 2022-10-07 | |||
| 2021-03-31 | -$3.08M 10-Q · filed 2022-05-27 | ||||
| 2020-09-30 | -$1.50M 10-Q/A · filed 2022-05-17 | -$960.00K 10-Q · filed 2021-11-23 | -$4.95M 10-Q/A · filed 2022-05-17 | -$3.90M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |